Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

The prevalence of food allergy is significantly lower in children with cystic fibrosis than in those without the condition in ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...

A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...

Affordable access to life-changing treatment for cystic fibrosis will be expanded to more Australians with a change to the ...

North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...

A family who know how devastating a cystic fibrosis diagnosis can be recently tackled an assault course in support of poorly ...

Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.

Cystic fibrosis (CF) is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive system and ...